BRENDAN LINDSEY: Open Payments
NPI 1457087496 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 15 payments from 9 companies in 2025. Trend: 2023 $957 · 2024 $1,000 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $82 |
| IMMUNITYBIO, INC. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| COLOPLAST CORP | 2 | $35 |
| TOLMAR, INC. | 1 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $25 |
| Procept Biorobotics Corporation | 1 | $22 |
Products named: GEMTESA, ANKTIVA, Xtandi, SpeediCath, JATENZO, PYLARIFY, XYOSTED, AQUABEAM ROBOTIC SYSTEM.
Industry payments across VA — which companies pay providers there.
